Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9325431 | Fertility and Sterility | 2005 | 6 Pages |
Abstract
We demonstrated that GnRH antagonist administration in infertile patients undergoing IVF did not alter the follicular fluid content of VEGF and inhibin A, and, probably, maturation and quality of oocytes as well. These results demonstrated the usefulness and safety of this drug on controlled ovarian stimulation (COS) protocols.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
João Sabino Ph.D., Nadiane M.D., Nina M.D., Andréia M.D., Eduardo Pandolfi Ph.D.,